David Windley
Stock Analyst at Jefferies
(3.53)
# 853
Out of 5,141 analysts
203
Total ratings
65.25%
Success rate
13.17%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $453.77 | +23.41% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $189.83 | +23.79% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $165.62 | +53.97% | 6 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Buy | $418 → $340 | $290.00 | +17.24% | 28 | Jan 28, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $100.37 | - | 1 | Dec 3, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $99.70 | +75.53% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $11.00 | -13.64% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $168.92 | +15.44% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $250.65 | +4.93% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $0.89 | +208.99% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $43.24 | +41.07% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $13.23 | -9.30% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $280.31 | +50.55% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $151.00 | +96.69% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.26 | +1,336.78% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $342.93 | +76.13% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $504.05 | -25.60% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $17.49 | -11.38% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $180.31 | +49.74% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $6.46 | +139.94% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $241.12 | +122.30% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $16.05 | +80.69% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $4.74 | +5,132.07% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.88 | - | 5 | Oct 9, 2017 |
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $453.77
Upside: +23.41%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $189.83
Upside: +23.79%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $165.62
Upside: +53.97%
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $418 → $340
Current: $290.00
Upside: +17.24%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $100.37
Upside: -
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $99.70
Upside: +75.53%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $11.00
Upside: -13.64%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $168.92
Upside: +15.44%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $250.65
Upside: +4.93%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.89
Upside: +208.99%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $43.24
Upside: +41.07%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $13.23
Upside: -9.30%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $280.31
Upside: +50.55%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $151.00
Upside: +96.69%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.26
Upside: +1,336.78%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $342.93
Upside: +76.13%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $504.05
Upside: -25.60%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $17.49
Upside: -11.38%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $180.31
Upside: +49.74%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $6.46
Upside: +139.94%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $241.12
Upside: +122.30%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $16.05
Upside: +80.69%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $4.74
Upside: +5,132.07%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.88
Upside: -